Blood Vanillic Alcohol Sulfate
Introduction
Section titled “Introduction”Background
Section titled “Background”Blood vanillic alcohol sulfate is a metabolite found in human circulation. It is a sulfated derivative of vanillic alcohol, a phenolic compound. Phenolic compounds are often derived from the diet, particularly from plant-based foods, or can be produced by gut microbiota metabolism. The process of sulfation is a common phase II metabolic reaction that converts lipophilic compounds into more water-soluble forms, facilitating their excretion from the body.
Biological Basis
Section titled “Biological Basis”Sulfate conjugation, which forms blood vanillic alcohol sulfate, is primarily catalyzed by sulfotransferases in various tissues, including the liver and intestines. This metabolic pathway is crucial for the detoxification and elimination of a wide range of endogenous and exogenous compounds. While sulfation generally aids in excretion, it can also play a role in modulating the biological activity of certain molecules. The presence and concentration of specific metabolites in serum, like vanillic alcohol sulfate, reflect the interplay between an individual’s diet, gut microbiome, and endogenous metabolic processes. The field of metabolomics aims to comprehensively measure such endogenous metabolites to provide a functional readout of the physiological state of the human body.[1]
Clinical Relevance
Section titled “Clinical Relevance”Variations in the levels of blood vanillic alcohol sulfate could serve as a biomarker for dietary intake of phenolic compounds, the activity of specific metabolic enzymes, or the health and composition of the gut microbiota. Changes in metabolite profiles in human serum have been linked to various physiological states and diseases, making them valuable for understanding disease mechanisms and identifying potential diagnostic markers.[1]Genetic variants can influence the homeostasis of key metabolites, and studying these associations can reveal insights into disease susceptibility.[1]
Social Importance
Section titled “Social Importance”Understanding metabolites like blood vanillic alcohol sulfate contributes to the broader goal of personalized medicine and nutrition. By identifying how genetic factors, diet, and lifestyle influence an individual’s metabolic profile, researchers can develop more targeted health interventions and dietary recommendations. Metabolomics, combined with genome-wide association studies (GWAS), allows for the systematic investigation of genetic influences on metabolic traits.[1]This research holds potential for advancing public health by offering new ways to assess health risks, monitor disease progression, and evaluate the effectiveness of treatments.
Limitations
Section titled “Limitations”Methodological and Statistical Constraints
Section titled “Methodological and Statistical Constraints”Many genome-wide association studies face challenges due to moderate cohort sizes, which can lead to insufficient statistical power to detect modest genetic associations, thereby increasing the likelihood of false negative findings. [2] Conversely, the inherent nature of genome-wide scans involves performing a vast number of statistical tests, a practice that can inflate the risk of false positive findings if not adequately addressed through rigorous statistical correction or subsequent replication efforts. [2]
The reliance on genotyping chips that assay only a subset of all available single nucleotide polymorphisms (SNPs), particularly those derived from earlier HapMap phases, presents a limitation as some genes or genuine associations may be missed due to incomplete genomic coverage.[3] While imputation methods are used to infer untyped SNPs, the observed discrepancy rates between imputed and directly genotyped SNPs, even if small, can potentially lead to weaker or overlooked associations. [4] Furthermore, using a more liberal threshold for genotyping call rates, though intended for inclusivity, may introduce lower quality data into the analyses. [5] Despite careful quality control measures for phenotype measurement, such as performing duplicate assays and requiring fasting before blood collection, the precise quantification of complex biological traits can still introduce variability. [6] Moreover, necessary participant exclusions, such as individuals not adhering to fasting protocols or those on specific medications, can limit the generalizability of findings to the broader population. [7]
Generalizability and Population-Specific Biases
Section titled “Generalizability and Population-Specific Biases”A significant limitation in many genetic association studies is the predominant focus on cohorts of European ancestry, which inherently restricts the generalizability of the findings to other ethnic or racial groups. [2] Although some research attempts to extend findings to multiethnic samples, the initial discovery and primary replication phases often occur in ethnically homogeneous populations, potentially overlooking ancestry-specific genetic effects or gene-environment interactions that vary across populations. [8] The specific characteristics of study cohorts, such as being largely composed of middle-aged to elderly individuals, can also limit the applicability of results to younger populations. [2] Additionally, if DNA collection occurs at later stages of a longitudinal study, it may introduce a survival bias, meaning the studied population might not fully represent the initial, broader cohort. [2]
Many analyses are conducted in a sex-pooled manner to mitigate the multiple testing burden, which means that genetic associations that are specific to only one sex may remain undetected. [3] While some studies have explicitly investigated and found no sex-specific effect modification for certain traits, this remains a potential limitation for other phenotypes where sex-linked biological pathways might play a role. [4] The absence of sex-specific analyses means that subtle but significant genetic influences that manifest differently between males and females could be overlooked in aggregated data.
Replication and Remaining Knowledge Gaps
Section titled “Replication and Remaining Knowledge Gaps”Replication in independent cohorts is widely recognized as the gold standard for validating findings from genome-wide association studies, yet a common observation is that only a fraction of initial associations are successfully replicated. [2] The failure to replicate can arise from various factors, including the presence of false positive findings in the original reports, substantial differences in cohort characteristics between discovery and replication studies, or insufficient statistical power in the replication cohorts. [2] These inconsistencies highlight the challenges in confirming genetic associations and emphasize the need for robust study designs.
Discrepancies in replication efforts can also stem from methodological variations, such as differences in sample size, the specific genetic markers utilized, or the genetic models (e.g., additive versus recessive or dominant) applied across different studies.[2] These methodological inconsistencies underscore the complexity of validating genetic associations and highlight the need for greater standardization in analytical approaches to ensure robust and reproducible results. While genome-wide association studies are effective at identifying statistical associations, the ultimate validation of these findings often necessitates follow-up with functional studies to elucidate the underlying biological mechanisms. [2] Furthermore, despite efforts to explore gene-by-environment interactions for some genetic loci, the full scope of environmental confounders and the intricate interplay between genes and the environment contributing to trait variability remain significant knowledge gaps [9] representing a component of missing heritability not fully accounted for by common genetic variants.
Variants
Section titled “Variants”The XPR1 gene encodes a protein that functions as a receptor for xenotropic and polytropic retroviruses, playing a critical role in cellular antiviral defense. Beyond its role in viral entry, XPR1is also essential for regulating phosphate export from cells, a process vital for maintaining intracellular phosphate homeostasis and supporting numerous metabolic pathways. Variants likers375356618 could potentially alter the protein’s structure or expression, thereby impacting its ability to regulate phosphate efflux or interact with viral particles.[1]Such changes in fundamental cellular processes could indirectly influence overall cellular metabolism and the processing of various compounds, potentially affecting the circulating levels of metabolites like blood vanillic alcohol sulfate.[2]
The LSM7 gene is a member of the LSm protein family, which is intimately involved in RNA processing, particularly in the assembly and function of small nuclear ribonucleoproteins (snRNPs) that are crucial for pre-mRNA splicing. Efficient and accurate gene expression and subsequent protein synthesis are dependent on proper RNA splicing, highlighting LSM7’s foundational role in cellular function and development. A genetic variation, such as rs192431673 , could influence the efficiency or fidelity of RNA splicing, potentially leading to altered levels or forms of various proteins. [10]These widespread effects on protein production could, in turn, impact enzymatic activities and metabolic pathways responsible for the synthesis or breakdown of a wide range of compounds, including blood vanillic alcohol sulfate.[1]
GNPATencodes glyceronephosphate O-acyltransferase, an enzyme pivotal for the initial step in the biosynthesis of ether lipids, such as plasmalogens. Ether lipids are significant structural components of cell membranes and participate in diverse cellular processes, including antioxidant defense and signal transduction. A genetic variation likers541076954 in GNPAT could affect the enzyme’s activity or stability, leading to altered levels of these critical lipids. [1]Disruptions in lipid metabolism can have far-reaching consequences for cellular function and overall metabolic homeostasis, potentially influencing the concentrations of other circulating metabolites, such as blood vanillic alcohol sulfate, due to the interconnected nature of metabolic pathways.[2]
Key Variants
Section titled “Key Variants”| RS ID | Gene | Related Traits |
|---|---|---|
| rs375356618 | XPR1 | blood vanillic alcohol sulfate measurement |
| rs192431673 | LSM7 | blood vanillic alcohol sulfate measurement |
| rs541076954 | GNPAT | blood vanillic alcohol sulfate measurement |
Biological Background
Section titled “Biological Background”Genetic and Metabolic Profiling in Blood
Section titled “Genetic and Metabolic Profiling in Blood”The field of metabolomics aims to comprehensively measure endogenous metabolites present in a cell or body fluid, providing a functional readout of an individual’s physiological state. [1] Genetic variants can significantly influence the homeostasis of key lipids, carbohydrates, and amino acids, leading to observable differences in metabolic profiles. [1]Genome-wide association studies (GWAS) are instrumental in identifying these genetic associations, linking specific single nucleotide polymorphisms (SNPs) to variations in metabolite levels within human serum.[1] Such studies often characterize lipid components by their glycerol moiety structure and fatty acid side chain composition, denoted as Cx:y, where ‘x’ signifies the total carbon atoms and ‘y’ the number of double bonds, providing insights into the molecular makeup of circulating lipids. [1]
Key Pathways of Lipid and Glucose Metabolism
Section titled “Key Pathways of Lipid and Glucose Metabolism”Lipid metabolism is a fundamental biological process, involving complex pathways for the biosynthesis and modification of membrane lipids and fatty acids. [11] Genetic variations in gene clusters, such as FADS1 FADS2, have been strongly associated with the fatty acid composition within phospholipids, indicating a genetic predisposition to certain lipid profiles. [12] A critical enzyme in cholesterol biosynthesis is 3-hydroxy-3-methylglutaryl coenzyme A reductase (HMGCR), which governs the mevalonate pathway. [13] Polymorphisms within HMGCR can impact the alternative splicing of its messenger RNA, thereby influencing circulating LDL-cholesterol levels. [14] Additionally, lecithin:cholesterol acyltransferase (LCAT) is an enzyme vital for cholesterol esterification, and its dysfunction leads to specific lipid deficiency syndromes. [15] Beyond lipids, genes like G6PC2are associated with fasting plasma glucose levels, highlighting genetic influences on glucose homeostasis.[16]
Molecular Regulation and Transport Mechanisms
Section titled “Molecular Regulation and Transport Mechanisms”Specific proteins and transporters play crucial roles in regulating metabolite concentrations in the blood. The SLC2A9gene encodes a newly identified urate transporter that significantly influences serum uric acid concentrations and its excretion, with notable sex-specific effects.[17]Similarly, glucose transporter-like protein-9 (GLUT9), which exists in various splice variants, is expressed in organs like the liver and kidney and its expression levels are altered in diabetic states [18]this transporter is also implicated in regulating serum uric acid levels.[19] Furthermore, the ABOhisto-blood group antigens are not merely surface markers but are covalently linked to several plasma proteins, including alpha 2-macroglobulin and von Willebrand factor.[20] Genetic variations in the ABO locus are associated with levels of soluble intercellular adhesion molecule-1 (ICAM-1) [21] a molecule whose gene expression is transcriptionally regulated by inflammatory cytokines through the NF-kappa B pathway. [22]
Systemic Health Implications
Section titled “Systemic Health Implications”Disruptions in metabolic homeostasis, often influenced by genetic factors, have broad systemic consequences and are linked to various pathophysiological processes. Elevated serum uric acid, for instance, is not only associated with gout[23]but can also serve as an indicator of renal vascular involvement in essential hypertension.[24]Genetic loci that influence plasma lipid concentrations are directly correlated with the risk of coronary artery disease[25] and a null mutation in APOC3 can confer a favorable plasma lipid profile and apparent cardioprotection. [26] Beyond metabolic disorders, the ICAM-1 gene has been associated with type 1 diabetes [27]highlighting the role of inflammation in disease development.[28] Moreover, the ABO blood group has been linked to various clinical outcomes, including peptic ulceration. [29] Overall, the interplay between genetic makeup and circulating metabolite levels provides crucial insights into the predisposition to and progression of numerous diseases, reflecting a functional readout of the body’s physiological state. [1]
References
Section titled “References”[1] Gieger, C. “Genetics meets metabolomics: a genome-wide association study of metabolite profiles in human serum.”PLoS Genet, 2008.
[2] Benjamin, E. J., et al. “Genome-wide association with select biomarker traits in the Framingham Heart Study.” BMC Med Genet, vol. 8, suppl. 1, 2007, p. S1.
[3] Yang, Q. “Genome-wide association and linkage analyses of hemostatic factors and hematological phenotypes in the Framingham Heart Study.”BMC Med Genet, 2007.
[4] Chen, Wei-Min, et al. “Variations in the G6PC2/ABCB11Genomic Region Are Associated with Fasting Glucose Levels.”Journal of Clinical Investigation, vol. 118, no. 6, 2008, pp. 2220-28.
[5] Vasan, RS. “Genome-wide association of echocardiographic dimensions, brachial artery endothelial function and treadmill exercise responses in the Framingham Heart Study.”BMC Med Genet, 2007.
[6] Melzer, D. “A genome-wide association study identifies protein quantitative trait loci (pQTLs).” PLoS Genet, 2008.
[7] Sabatti, C. “Genome-wide association analysis of metabolic traits in a birth cohort from a founder population.”Nat Genet, 2008.
[8] Kathiresan, S. “Common variants at 30 loci contribute to polygenic dyslipidemia.” Nat Genet, 2008.
[9] Dehghan, A. “Association of three genetic loci with uric acid concentration and risk of gout: a genome-wide association study.”Lancet, 2008.
[10] Wallace, Cathryn, et al. “Genome-wide association study identifies genes for biomarkers of cardiovascular disease: serum urate and dyslipidemia.”American Journal of Human Genetics, vol. 82, no. 1, 2008, pp. 139–149.
[11] Vance, J. E. “Membrane lipid biosynthesis.” Encyclopedia of Life Sciences, John Wiley & Sons, Ltd: Chichester, 2001.
[12] Schaeffer, L., et al. “Common genetic variants of the FADS1 FADS2 gene cluster and their reconstructed haplotypes are associated with the fatty acid composition in phospholipids.” Hum Mol Genet, vol. 15, no. 10, 2006, pp. 1745–1756.
[13] Edwards, P. A., et al. “Improved methods for the solubilization and assay of hepatic 3-hydroxy-3-methylglutaryl coenzyme A reductase.” J Lipid Res, vol. 20, no. 1, 1979, pp. 40–46.
[14] Burkhardt, R., et al. “Common SNPs in HMGCR in micronesians and whites associated with LDL-cholesterol levels affect alternative splicing of exon13.” Arterioscler Thromb Vasc Biol, vol. 28, no. 10, 2008, pp. 1827–1834.
[15] Kuivenhoven, J. A., et al. “The molecular pathology of lecithin:cholesterol acyltransferase (LCAT) deficiency syndromes.” J Lipid Res, vol. 38, no. 2, 1997, pp. 191–205.
[16] Bouatia-Naji, N., et al. “A polymorphism within the G6PC2 gene is associated with fasting plasma glucose levels.”Science, vol. 320, no. 5879, 2008, pp. 1085–1089.
[17] Do¨ring, Angela, et al. “SLC2A9 Influences Uric Acid Concentrations with Pronounced Sex-Specific Effects.”Nature Genetics, vol. 40, no. 4, 2008, pp. 430-36.
[18] Augustin, R., et al. “Identification and characterization of human glucose transporter-like protein-9 (GLUT9): alternative splicing alters trafficking.”J Biol Chem, vol. 279, no. 16, 2004, pp. 16229–16236.
[19] Li, S., et al. “The GLUT9Gene Is Associated with Serum Uric Acid Levels in Sardinia and Chianti Cohorts.”PLoS Genetics, vol. 3, no. 11, 2007, e194.
[20] O’Donnell, J. S., and M. A. Laffan. “The relationship between ABO histo-blood group, factor VIII and von Willebrand factor.” Transfusion Medicine, vol. 11, no. 5, 2001, pp. 343–351.
[21] Pare, G., et al. “Novel association of ABO histo-blood group antigen with soluble ICAM-1: results of a genome-wide association study of 6,578 women.” PLoS Genet, vol. 4, no. 7, 2008, p. e1000118.
[22] Ledebur, H. C., and T. P. Parks. “Transcriptional regulation of the intercellular adhesion molecule-1 gene by inflammatory cytokines in human endothelial cells. Essential roles of a variant NF-kappa B site and p65 homodimers.” J Biol Chem, vol. 270, no. 16, 1995, pp. 933–943.
[23] Vitart, V., et al. “SLC2A9 is a newly identified urate transporter influencing serum urate concentration, urate excretion and gout.”Nat Genet, vol. 40, no. 4, 2008, pp. 437–442.
[24] Messerli, F. H., et al. “Serum uric acid in essential hypertension: an indicator of renal vascular involvement.”Ann Intern Med, vol. 93, no. 6, 1980, pp. 817–821.
[25] Willer, C. J., et al. “Newly identified loci that influence lipid concentrations and risk of coronary artery disease.”Nat Genet, vol. 40, no. 2, 2008, pp. 189–197.
[26] Pollin, T. I., et al. “A null mutation in human APOC3 confers a favorable plasma lipid profile and apparent cardioprotection.” Science, vol. 322, no. 5908, 2008, pp. 1702–1705.
[27] Nejentsev, S., et al. “Association of intercellular adhesion molecule-1 gene with type 1 diabetes.” Lancet, vol. 362, no. 9397, 2003, pp. 1723–1724.
[28] Crawford, D. C., et al. “Haplotype diversity across 100 candidate genes for inflammation, lipid metabolism, and blood pressure regulation in two populations.” Am J Hum Genet, vol. 74, no. 4, 2004, pp. 610–622.
[29] Aird, I., et al. “The blood groups in relation to peptic ulceration and carcinoma of colon, rectum, breast, and bronchus; an association between the ABO groups and peptic ulceration.” Br Med J, vol. 2, no. 4883, 1954, pp. 315–321.